Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

Enrolling by invitation · Phase 1/Phase 2

Conditions studied: Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia

In brief

Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial

Key facts

Study ID

NCT07299123

Run by

Chinese PLA General Hospital

People needed

40

Starts

2022-08-01

Expected to finish

2026-12-31

Last updated by the study team

2026-06-23

Who can join

Age: 6 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

Where it is running

• 28 Fuxing Road, Beijing, China. — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.